Royal Bank of Canada’s Climb Bio, Inc. Common Stock CLYM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4K | Sell |
2,852
-1,744
| -38% | -$2.45K | ﹤0.01% | 6326 |
|
|
2025
Q1 | $6K | Sell |
4,596
-96
| -2% | -$125 | ﹤0.01% | 5941 |
|
|
2024
Q4 | $8K | Buy |
4,692
+1,224
| +35% | +$2.09K | ﹤0.01% | 5931 |
|
|
2024
Q3 | $17K | Buy |
3,468
+2,782
| +406% | +$13.6K | ﹤0.01% | 5699 |
|
|
2024
Q2 | $5K | Buy |
686
+623
| +989% | +$4.54K | ﹤0.01% | 6166 |
|
|
2024
Q1 | $0 | Buy |
63
+27
| +75% | – | ﹤0.01% | 7061 |
|
|
2023
Q4 | $0 | Sell |
36
-20
| -36% | – | ﹤0.01% | 7039 |
|
|
2023
Q3 | $0 | Sell |
56
-69
| -55% | – | ﹤0.01% | 7079 |
|
|
2023
Q2 | $0 | Buy |
+125
| New | – | ﹤0.01% | 7167 |
|
|
2022
Q4 | – | Sell |
-111
| Closed | – | – | 7233 |
|
|
2022
Q3 | $0 | Buy |
111
+83
| +296% | – | ﹤0.01% | 7365 |
|
|
2022
Q2 | $0 | Sell |
28
-342
| -92% | – | ﹤0.01% | 7199 |
|
|
2022
Q1 | $3K | Sell |
370
-1,233
| -77% | -$10K | ﹤0.01% | 6927 |
|
|
2021
Q4 | $17K | Buy |
1,603
+823
| +106% | +$8.73K | ﹤0.01% | 6337 |
|
|
2021
Q3 | $14K | Buy |
+780
| New | +$14K | ﹤0.01% | 6323 |
|